Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected in Denmark.
Recent Posts
- ACA cliff may mean ‘huge premium shock’ for 22 million people in 2026, expert says
- ‘We’re all kind of in shock.’ Oracle’s revenue projections leave analysts slack-jawed
- Trump blocked from firing Fed Governor Lisa Cook as lawsuit plays out
- More investors want public and private assets in their portfolio. Now there’s a benchmark to track this combo
- Poland shoots down Russian drones as Ukraine warns Putin is ‘testing the West’